---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-005557"
form_type: "8-K"
ticker: "BYSI"
cik: "0001677940"
company_name: "BeyondSpring Inc."
filed_at: "2026-08-14T21:15:17+00:00"
generated_at: "2026-08-14T21:16:13.257049+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BeyondSpring Q2 net loss $1.8M; ASCO data show 58% 24-month OS in post-ICI NSCLC

## Summary
- Q2 2026 net loss $1.8M vs $1.9M YoY; cash and short-term investments $6.5M at June 30, 2026.
- ASCO 2026 Phase 2 (n=47): median PFS 7.0 mo, ORR 18.2%, DCR 79.5%, 24-month OS 58.0%.
- Leadership effective July 1, 2026: Min Qiu CEO, Jen Majeti Vice Chairman, Na Li CFO.
- DUBLIN-4 planned confirmatory Phase 3: 442 patients, non-squamous EGFR-wild-type NSCLC post-ICI.

## SEC filing metadata
- accession: 0001171843-26-005557
- form_type: 8-K
- ticker: BYSI
- cik: 0001677940
- company_name: BeyondSpring Inc.
- filed_at: 2026-08-14T21:15:17+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677940/000117184326005557/0001171843-26-005557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677940/000117184326005557/f8k_081426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-005557
- JSON: https://secwatch.observer/filing/0001171843-26-005557.json
- Plain text: https://secwatch.observer/filing/0001171843-26-005557.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.